Cite
HPTLC-MALDI MS for (glyco)sphingolipid multiplexing in tissues and blood: A promising strategy for biomarker discovery and clinical applications
MLA
Enrica, Torretta, et al. HPTLC-MALDI MS for (Glyco)Sphingolipid Multiplexing in Tissues and Blood: A Promising Strategy for Biomarker Discovery and Clinical Applications. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....404147a4dce11d8add71d8ac6215460a&authtype=sso&custid=ns315887.
APA
Enrica, T., Chiara, F., Michele, V., & Cecilia, G. (2016). HPTLC-MALDI MS for (glyco)sphingolipid multiplexing in tissues and blood: A promising strategy for biomarker discovery and clinical applications.
Chicago
Enrica, Torretta, Fania Chiara, Vasso Michele, and Gelfi Cecilia. 2016. “HPTLC-MALDI MS for (Glyco)Sphingolipid Multiplexing in Tissues and Blood: A Promising Strategy for Biomarker Discovery and Clinical Applications,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....404147a4dce11d8add71d8ac6215460a&authtype=sso&custid=ns315887.